Amphetamine and fenproporex levels following multidose administration of fenproporex

被引:27
|
作者
Cody, JT
Valtier, S
机构
[1] Wilford Hall USAF Med Ctr, Clin Res Squadron, Lackland AFB, TX 78236 USA
[2] Univ Alabama, Dept Justice Sci, Grad Program Forens Sci, Birmingham, AL 35294 USA
关键词
D O I
10.1093/jat/23.3.187
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Drugs that are metabolized to amphetamine or methamphetamine are potentially of significant concern in the interpretation of positive drug- testing results for amphetamines. A number of different drugs have been reported to produce amphetamine in the urine of users. One of these compounds, fenproporex, has been shown to be metabolized to amphetamine, and previous reports indicated the parent compound could be detected at low levels for up to 48 h. Administration of fenproporex for seven days (one 10- mg dose per day) to five healthy volunteers resulted in amphetamine being detected in the urine of all subjects. Peak concentrations of amphetamine ranged from approximately 2850 to 4150 ng/mL. Amphetamine could be detected (≥ 5 ng/mL) in the urine for up to nearly 170 h after the last dose. Analysis of the metabolically produced amphetamine showed the presence of both enantiomers, which can be helpful in the differentiation of some illicit amphetamine use from the use of this precursor drug. In addition, evaluation of the enantiomeric composition of the metabolite (amphetamine) can be a valuable tool in the interpretation of time since last dose. More significantly, all samples that contained amphetamine at a concentration of ≥ 500 ng/mL were shown to also contain detectable amounts of the parent compound.
引用
收藏
页码:187 / 194
页数:8
相关论文
共 50 条
  • [1] Detection of amphetamine following administration of fenproporex
    Cody, JT
    Valtier, S
    [J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 1996, 20 (06) : 425 - 431
  • [2] Fenproporex and Amphetamine Pharmacokinetics in Oral Fluid After Controlled Oral Administration of Fenproporex
    Comiran, Eloisa
    Souza, Daniele Zago
    Boehl, Paula Otero
    Mariotti, Kristiane de Cassia
    Pechansky, Flavio
    Arruda Vieira Duarte, Paulina do Carmo
    De Boni, Raquel Brandini
    Froeehlich, Pedro Eduardo
    Limberger, Renata Pereira
    [J]. THERAPEUTIC DRUG MONITORING, 2012, 34 (05) : 545 - 553
  • [3] AMPHETAMINE CONCENTRATIONS IN RAT-BRAIN AND HUMAN URINE AFTER FENPROPOREX ADMINISTRATION
    TOGNONI, G
    MORSELLI, PL
    GARATTINI, S
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1972, 20 (01) : 125 - +
  • [4] Amphetamine, clobenzorex, and 4-hydroxyclobenzorex levels following multidose administration of clobenzorex
    Cody, JT
    Valtier, S
    [J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 2001, 25 (03) : 158 - 165
  • [5] Metabolic production of amphetamine following multidose administration of clobenzorex
    Baden, KL
    Valtier, S
    Cody, JT
    [J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 1999, 23 (06) : 511 - 517
  • [6] PHARMACOLOGICAL PROPERTIES OF FENPROPOREX IN RATS
    CESSIONF.A
    [J]. ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1970, 187 (01): : 192 - &
  • [7] Amphetamine excretion profile following multidose administration of mixed salt amphetamine preparation
    Cody, JT
    Valtier, S
    Nelson, SL
    [J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 2004, 28 (07) : 563 - 574
  • [8] Effects of chronic administration of fenproporex on cognitive and non-cognitive behaviors
    Goncalves, Cinara L.
    Furlanetto, Camila B.
    Valvassori, Samira S.
    Bavaresco, Daniela V.
    Varela, Roger B.
    Budni, Josiane
    Quevedo, Joao
    Streck, Emilio L.
    [J]. METABOLIC BRAIN DISEASE, 2015, 30 (02) : 583 - 588
  • [9] Acute administration of fenproporex increased acetylcholinesterase activity in brain of young rats
    Teodorak, Brena P.
    Ferreira, Gabriela K.
    Scaini, Giselli
    Wessler, Leticia B.
    Heylmann, Alexandra S.
    Deroza, Pedro
    Ssori, Samira S. Valva
    Zugno, Alexandra I.
    Quevedo, Joao
    Streck, Emilio L.
    [J]. ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS, 2015, 87 (02): : 1389 - 1395
  • [10] Effects of chronic administration of fenproporex on cognitive and non-cognitive behaviors
    Cinara L. Gonçalves
    Camila B. Furlanetto
    Samira S. Valvassori
    Daniela V. Bavaresco
    Roger B. Varela
    Josiane Budni
    João Quevedo
    Emilio L. Streck
    [J]. Metabolic Brain Disease, 2015, 30 : 583 - 588